Okla. Stat. tit. 63, § 63-2-309

A. 1. Except for dosages medically required for a period not

to exceed forty-eight (48) hours which are administered by or on

direction of a practitioner, other than a pharmacist, or medication

dispensed directly by a practitioner, other than a pharmacist, to an

ultimate user, no controlled dangerous substance included in

Schedule II, which is a prescription drug as determined under

regulation promulgated by the Board of Pharmacy, shall be dispensed

without an electronic prescription of a practitioner; provided, that

in emergency situations, as prescribed by the Board of Pharmacy by

regulation, such drug may be dispensed upon oral prescription

reduced promptly to writing and filed by the pharmacist in a manner

to be prescribed by rules and regulations of the Director of the

Oklahoma State Bureau of Narcotics and Dangerous Drugs Control.

2. Electronic prescribing shall be utilized for Schedules II,

III, IV and V, subject to the requirements set forth in 21 CFR,

Section 1311 et seq.

3. An electronic prescription with electronic signature may

serve as an original prescription, subject to the requirements set

forth in 21 CFR, Section 1311 et seq.

4. Prescriptions shall be retained in conformity with the

requirements of this section and Section 2-307 of this title. No

prescription for a Schedule II substance may be refilled.

5. The electronic prescription requirement provided for in this

section shall not apply to prescriptions for controlled dangerous

substances issued by any of the following:

a. a person licensed to practice veterinary medicine,

b. a practitioner who experiences temporary technological

or electrical failure or other extenuating

circumstance that prevents the prescription from being

transmitted electronically; provided, however, that

the practitioner documents the reason for this

exception in the medical record of the patient,

c. a practitioner, other than a pharmacist, who dispenses

directly to an ultimate user,

Oklahoma Statutes - Title 63. Public Health and Safety Page 945

d. a practitioner who orders a controlled dangerous

substance to be administered through an on-site

pharmacy in:

(1) a hospital as defined in Section 1-701 of this

title,

(2) a nursing facility as defined in Section 1-1902

of this title,

(3) a hospice inpatient facility as defined in

Section 1-860.2 of this title,

(4) an outpatient dialysis facility,

(5) a continuum of care facility as defined in

Section 1-890.2 of this title, or

(6) a penal institution listed in Section 509 of

Title 57 of the Oklahoma Statutes,

e. a practitioner who orders a controlled dangerous

substance to be administered through a hospice program

including but not limited to a hospice program that

provides hospice services in the private residence of

a patient or in a long-term care facility where the

patient resides. As used in this subparagraph,

“hospice program” has the same meaning as provided by

Section 1-860.2 of this title,

f. a practitioner who writes a prescription to be

dispensed by a pharmacy located on federal property,

provided the practitioner documents the reason for

this exception in the medical record of the patient,

g. a practitioner that has received a waiver or extension

from his or her licensing board,

h. a practitioner who prescribes a controlled dangerous

substance for a supply that when taken as prescribed

would be consumed within seventy-two (72) hours, or

i. a practitioner who determines that an electronic

prescription cannot be issued in a timely manner and

the condition of the patient is at risk.

6. Electronic prescriptions may be utilized under the following

circumstances:

a. compounded prescriptions,

b. compounded infusion prescriptions, or

c. prescriptions issued under approved research

protocols.

7. A pharmacist who receives a written, oral or facsimile

prescription shall not be required to verify that the prescription
timely manner and

the condition of the patient is at risk.

6. Electronic prescriptions may be utilized under the following

circumstances:

a. compounded prescriptions,

b. compounded infusion prescriptions, or

c. prescriptions issued under approved research

protocols.

7. A pharmacist who receives a written, oral or facsimile

prescription shall not be required to verify that the prescription

falls under one of the exceptions provided for in paragraph 6 of

this subsection. Pharmacists may continue to dispense medications

from otherwise valid written, oral or facsimile prescriptions that

are consistent with the provisions of this section.

Oklahoma Statutes - Title 63. Public Health and Safety Page 946

8. Practitioners shall indicate in the health record of a

patient that an exception to the electronic prescription requirement

was utilized.

9. All prescriptions issued pursuant to paragraph 5 and

subparagraph c of paragraph 6 of this subsection shall be on an

official prescription form approved by the Oklahoma State Bureau of

Narcotics and Dangerous Drugs Control if not issued electronically.

10. a. Practitioners shall be registered with the Oklahoma

State Bureau of Narcotics and Dangerous Drugs Control

in order to purchase official prescription forms.

Such registration shall include, but not be limited

to, the primary address and the address of each place

of business to be imprinted on official prescription

forms. Any change to a registered practitioner’s

registered address shall be promptly reported to the

practitioner’s licensing board and the Bureau by the

practitioner in a manner approved by the Bureau.

b. Where the Bureau has revoked the registration of a

registered practitioner, the Bureau may revoke or

cancel any official prescription forms in the

possession of the registered practitioner. Any

revocation or any suspension shall require the

registered practitioner to return all unused official

prescription forms to the Bureau within fifteen (15)

calendar days after the date of the written

notification.

c. A practitioner that has had any license to practice

terminated, revoked or suspended by a state or federal

agency may, upon restoration of such license or

certificate, register with the Bureau.

11. a. Official prescription forms shall be purchased at the

expense of the practitioner or the employer of the

practitioner from a list of vendors approved by the

Bureau.

b. Official prescription forms issued to a registered

practitioner shall be imprinted with the primary

address and may include other addresses listed on the

registration of the practitioner to identify the place

of origin. Such prescriptions shall be sent only to

the primary address of the registered practitioner.

c. Official prescription forms of a registered

practitioner shall be used only by the practitioner

designated on the official prescription form.

d. The Bureau may revoke or cancel official prescription

forms in possession of registered practitioners when

the license of such practitioner is suspended,

terminated or revoked.

Oklahoma Statutes - Title 63. Public Health and Safety Page 947

e. Official prescription forms of registered

practitioners who are deceased or who no longer

prescribe shall be returned to the Bureau at a

designated address. If the registered practitioner is

deceased, it is the responsibility of the registered

practitioner’s estate or lawful designee to return

such forms.

f. The Bureau may issue official prescription forms to

employees or agents of the Bureau and other government

agencies for the purpose of preventing, identifying,

investigating and prosecuting unacceptable or illegal

practices by providers and other persons and assisting

in the recovery of overpayments under any program

operated by the state or paid for with state funds.

Such prescription forms shall be issued for this

purpose only to individuals who are authorized to
he Bureau and other government

agencies for the purpose of preventing, identifying,

investigating and prosecuting unacceptable or illegal

practices by providers and other persons and assisting

in the recovery of overpayments under any program

operated by the state or paid for with state funds.

Such prescription forms shall be issued for this

purpose only to individuals who are authorized to

conduct investigations on behalf of the Bureau or

other government agencies as part of their official

duties. Individuals and agencies receiving such

prescription forms for this purpose shall provide

appropriate assurances to the Bureau that adequate

safeguards and security measures are in place to

prevent the use of such prescription forms for

anything other than official government purposes.

12. a. Adequate safeguards and security measures shall be

undertaken by registered practitioners holding

official prescription forms to assure against the

loss, destruction, theft or unauthorized use of the

forms. Registered practitioners shall maintain a

sufficient but not excessive supply of such forms in

reserve.

b. Registered practitioners shall immediately notify the

Bureau, in a manner designated by the Bureau, upon

their knowledge of the loss, destruction, theft or

unauthorized use of any official prescription forms

issued to them, as well as the failure to receive

official prescription forms within a reasonable time

after ordering them from the Bureau.

c. Registered practitioners shall immediately notify the

Bureau upon their knowledge of any diversion or

suspected diversion of drugs pursuant to the loss,

theft or unauthorized use of prescriptions.

B. 1. Except for dosages medically required for a period not

to exceed seventy-two (72) hours which are administered by or on

direction of a practitioner other than a pharmacist or medication

dispensed directly by a practitioner, other than a pharmacist, to an

ultimate user, or the circumstances provided for in paragraphs 5 and

Oklahoma Statutes - Title 63. Public Health and Safety Page 948

6 of subsection A of this section, no controlled dangerous substance

included in Schedule III or IV, which is a prescription drug as

determined under regulation promulgated by the Board of Pharmacy,

shall be dispensed without an electronic prescription.

2. Any prescription for a controlled dangerous substance in

Schedule III, IV or V may not be filled or refilled more than six

(6) months after the date thereof or be refilled more than five

times after the date of the prescription, unless renewed by the

practitioner.

C. Whenever it appears to the Director of the Oklahoma State

Bureau of Narcotics and Dangerous Drugs Control that a drug not

considered to be a prescription drug under existing state law or

regulation of the Board of Pharmacy should be so considered because

of its abuse potential, the Director shall so advise the Board of

Pharmacy and furnish to the Board all available data relevant

thereto.

D. 1. “Prescription”, as used in this section, means a

written, oral or electronic order by a practitioner to a pharmacist

for a controlled dangerous substance for a particular patient, which

specifies the date of its issue, and the full name and address of

the patient and, if the controlled dangerous substance is prescribed

for an animal, the species of the animal, the name and quantity of

the controlled dangerous substance prescribed, the directions for

use, the name and address of the owner of the animal and, if

written, the signature of the practitioner. When electronically

prescribed, the full name of the patient may include the name and

species of the animal.

2. “Registered practitioner”, as used in this section, means a

licensed practitioner duly registered with the Oklahoma State Bureau

of Narcotics and Dangerous Drugs Control authorized to purchase

official prescription forms.
animal and, if

written, the signature of the practitioner. When electronically

prescribed, the full name of the patient may include the name and

species of the animal.

2. “Registered practitioner”, as used in this section, means a

licensed practitioner duly registered with the Oklahoma State Bureau

of Narcotics and Dangerous Drugs Control authorized to purchase

official prescription forms.

E. No person shall solicit, dispense, receive or deliver any

controlled dangerous substance through the mail, unless the ultimate

user is personally known to the practitioner and circumstances

clearly indicate such method of delivery is in the best interest of

the health and welfare of the ultimate user.